Detalhe da pesquisa
1.
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Gynecol Oncol
; 180: 35-43, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041901
2.
Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Cancer Immunol Immunother
; 72(1): 183-191, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35779095
3.
Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study.
Gynecol Oncol
; 174: 213-223, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37229879
4.
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
N Engl J Med
; 381(20): 1929-1939, 2019 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31722153
5.
Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer.
Gynecol Oncol
; 164(1): 12-17, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34763937
6.
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
Cancer
; 126(6): 1274-1282, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880826
7.
Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy.
Gynecol Oncol
; 158(2): 303-308, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32507515
8.
Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer.
Gynecol Oncol
; 159(2): 418-425, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814642
9.
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer.
Gynecol Oncol
; 157(1): 214-221, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959492
10.
A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
Gynecol Oncol
; 155(3): 393-399, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31653510
11.
A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
Gynecol Oncol
; 154(2): 294-301, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31174889
12.
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.
Gynecol Oncol
; 152(2): 251-258, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470581
13.
Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance.
J Natl Compr Canc Netw
; 17(9): 1083-1087, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31487684
14.
NCCN Guidelines Insights: Ovarian Cancer, Version 1.2019.
J Natl Compr Canc Netw
; 17(8): 896-909, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390583
15.
A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer.
Int J Gynecol Cancer
; 28(6): 1176-1182, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29757876
16.
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(6): 779-791, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438473
17.
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 14(9): 1134-63, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27587625
18.
A Phase 2, Single Arm Study of Iniparib in Patients With BRCA1 or BRCA2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
Int J Gynecol Cancer
; 26(2): 255-60, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26745694
19.
Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer.
Cancer Discov
; 14(1): 49-65, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849038
20.
Ovarian cancer, version 2.2013.
J Natl Compr Canc Netw
; 11(10): 1199-209, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24142821